I am passionate about delivering outlier outcomes for my clients by taking a thoughtful and tenacious approach to deal execution.
Chris advises clients across the technology and healthcare industries with a specific focus on healthcare information technology (HCIT).
He specializes in providing mergers and acquisitions advisory services for private equity groups, public companies and private and family-owned businesses.
Prior to Lincoln, Chris worked at an investment bank based in Southern California. He joined Lincoln’s New York office in 2014 and helped establish the San Francisco office in 2018.
Chris earned a Bachelor of Arts from Cornell University.
Recent Transactions in Healthcare
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Lincoln International advised EverVet Partners, a portfolio company of Tailwind Capital, on receiving a significant investment from Freeman Spogli & Co.
Lincoln International has advised All About Children on its sale to Partou, a portfolio company of Waterland Private Equity
Lincoln International advised SEKISUI CHEMICAL on the sale of SEKISUI XENOTECH to BioIVT, a portfolio company of Linden Capital Partners
Meet our Senior Team in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt